You are here: Industry Insights > API

News List

India ramping up API manufacturing: NITI Aayog CEO expresspharma
September 17, 2020
Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant.
CORONA Remedies picks up stake in La Chandra Pharmalab expresspharma
September 08, 2020
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs.
Piramal to Deliver Integrated Services to Epirium contractpharma
August 28, 2020
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
NPPA rejects IPA request for upward price revision of five per cent on all drugs expresspharma
August 20, 2020
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19 period, but it does not validate the claim of IPA for a price increase.
India’s CMO market is hotbed--- for global PE investment: GlobalData expresspharma
August 18, 2020
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China.
Ipca Labs is setting up API manufacturing facility in Dewas, MP expresspharma
August 17, 2020
It is in the process of procuring environmental clearance for the new plant being built with an initial capital outlay of about Rs 250 crores.
Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet expresspharma
August 17, 2020
Hyderabad-based, Lee Pharma has received DCGI’s approval for manufacturing and marketing of active pharmaceutical ingredients (API) for favipiravir in India.
Everest Organics develops remdesivir API expresspharma
August 11, 2020
The company has plans for the development of more products in the anti-viral segments in the future.
FDA proposes four APIs for bulk substances list for outsourcing facilities europeanpharmaceuticalreview
August 03, 2020
Four APIs are being considered by the FDA for its bulk drug substances list for potential use by outsourcing facilities when compounding if there is a clinical need.
Avra Laboratories gets CDSCO nod for favipiravir API expresspharma
July 29, 2020
The company informed that it is now supplying commercial quantities to Cipla for the launch of Ciplenza.